failure to respond or late response
on 08 May 2019
Last Applicant/ Owned by
Sir John Rogerson's Quay
Dublin
IE
Serial Number
87699921 filed on 28th Nov 2017
Registration Number
N/A
Correspondent Address
JOHN PICKERILL
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of the letter "Z" in a stylized font centered within a circle where the color teal transitions first to light blue, then back to teal, and finally to the color light green from left to right with a vertical light green line to the right, followed by the term "ZACOL" in dark blue font with the subscripted letters "NMX" in teal font. Medicines for intestinal disorders; pharmaceutiRead More
Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the human body; Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the colon; Enema apparatus; Enema syringes; Enema apparatus for medical purposes; Medical apparatus for introducing enema preparations into the human body; Injection syringes; Syringes for medical purposes; Surgical devices and instruments; Disposable syringes; Medical device for use in diagnosis and treatment of the gastro-intestinal tract
Medicines for intestinal disorders; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of diarrhea, antibiotic-associated diarrhea, travellers' diarrhea, for colon and digestive system health and regulation, for improving energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for use in sanitary preparations for medical purposes, namely, nutraceutical preparations for colon and digestive system health and regulation, for maintenance and improvement of energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for stimulating the growth of intestinal flora, restoring energy and metabolism of the colocyte and rescuing of the colonic mucosal trophism; pharmaceutical preparations for the treatment of colon disorders; pharmaceutical preparations for improving epithelial vitality and repair; pharmaceutical preparations for the prevention or treatment of cancer; pharmaceutical preparations for the prevention or treatment of colorectal cancer; pharmaceutical preparations for restoring the metabolic balance; pharmaceutical preparations for improving the trophic conditions of the mucosa; pharmaceutical preparations for regulating human gut homeostasis; pharmaceutical preparations for the treatment of gastro-intestinal disorders; pharmaceutical preparations for the treatment of inflammatory bowel disease, motility and functional disorders of the bowel such as IBS and colorectal tumours; pharmaceutical preparations for the maintenance of colon eubiosis; pharmaceutical preparations for decreasing intestinal inflammation; pharmaceutical preparations for promoting, supporting and maintaining a healthy colon; pharmaceutical preparations for the treatment of colitis, ulcerative colitis, Crohn's disease, radiation colitis, pouchitis, infectious colitis and shigellosis; pharmaceutical preparations for the treatment of polyposis of the colon; pharmaceutical preparations for the treatment of pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical and veterinary preparations in the form of tablets, capsules, sugar-coated pills, granules, powders or suppositories for use in treating gastrointestinal diseases and conditions; Pharmaceutical preparations, namely, anti-flatulars; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic beverages and food adapted for medical use; pharmaceutical preparations for the treatment of the intestinal infections; pharmaceutical preparations used to treat gastro-intestinal diseases and conditions, diagnostic agents, preparations and substances related to the gastro-intestinal field for medical purposes; medical preparation based on butyric acid and inulin that contributes to the restoration of intestinal barrier; lactic ferments for pharmaceutical use; biological preparations for use in the gastrointestinal diseases and conditions; food supplements; dietary supplements; vitamin supplements; nutritional supplements; dietary supplemental drinks; vitamin preparations in the form of food supplements; nutraceutical products for use as dietary supplements; Nutraceutical preparations for therapeutic or medical purposes; Mineral supplements for human use
No 87699921
No Service/Collective Mark
No 76724
No
No
No
No
No
No
No
No
26.01.01 -
Circles as carriers or as single line borders
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
The mark consists of the letter "Z" in a stylized font centered within a circle where the color teal transitions first to light blue, then back to teal, and finally to the color light green from left to right with a vertical light green line to the right, followed by the term "ZACOL" in dark blue font with the subscripted letters "NMX" in teal font.
| Status Date | Action Taken |
|---|---|
| 08th May 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 08th May 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 10th Oct 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 10th Oct 2018 | FINAL REFUSAL E-MAILED |
| 10th Oct 2018 | FINAL REFUSAL WRITTEN |
| 13th Sep 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th Sep 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 13th Sep 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 14th Mar 2018 | NON-FINAL ACTION E-MAILED |
| 14th Mar 2018 | NON-FINAL ACTION WRITTEN |
